Table 2.
Summary information of cis-SNPs for the ten cancers and the correlation of cis-SNP effects for each gene in TCGA and GTEx
| Cancer | Median | M (%) | R2 > 0.10 (%) |
|---|---|---|---|
| ACC | 3096 | 5227 (75.5) | 237 (3.4) |
| BRCA | 2878 | 3191 (75.3) | 265 (6.3) |
| COAD | 3478 | 4724 (69.8) | 283 (4.2) |
| LIHC | 3119 | 4018 (73.5) | 191 (3.5) |
| LUAD | 3534 | 4701 (77.5) | 232 (3.8) |
| LUSC | 3313 | 4149 (75.9) | 289 (5.3) |
| OV | 1571 | 3176 (70.9) | 766 (17.1) |
| PAAD | 3560 | 5067 (75.5) | 203 (3.0) |
| STAD | 3397 | 4176 (76.2) | 174 (3.2) |
| UCEC | 3324 | 4663 (73.8) | 137 (3.4) |
Median: the median number of cis-SNPs across genes; R2: the determination coefficient of the cis-SNPs effects for each gene in the linear regression; M: the number of genes whose regression coefficient is significant (FDR < 0.05)